Increased levels of tissue plasminogen activator antigen and factor VIII activity in nonvalvular atrial fibrillation: Relation to predictors of thromboembolism

Journal of Cardiovascular Electrophysiology

Volumn 12, Issue 8, 2001, Pages 877-884

  Wang, Tzung Dau ^a   Chen, Wen Jone ^a   Su, Sophia Seh Y I ^a   Su, T A Chen ^a   Chen, Ming Fong ^a   Liau, Chiau Suong ^a   Yuan Teh, L E E ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Coagulation; Plasminogen activators; Risk factors; Thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 8; CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034881407     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2001.00877.x     Document Type: Article

References (35)

1. Atrial fibrillation is an independent risk factor for stroke: The Framingham Study
2. Iscbemic stroke in patients with atrial fibrillation. Clinical characteristics and the effect of aspirin
3. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillations
4. Non-rheumatic atrial fibrillation as a risk factor for stroke
5. Hemostatic and hemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation
6. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation
7. Fibrin d-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultralow-dose warfarin and aspirin
8. Nonvalvular atrial fibrillation: Evidence for a prothrombotic state
9. Prothrombin fragment F1+2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation
10. Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III Study
11. Vascular-bed specific hemostasis and hypercoagulable states
12. A reliable marker of endothelial cell dysfunction: Does it exist?
13. Prospective study of endogenous tissue plasminogen activator and risk of stroke
14. Measurement of factor VIII. A potential risk factor for vascular disease
15. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage
16. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma in Raynaud's phenomenon
17. Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation
18. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
19. Atrial fibrillation and ethnicity
20. Chin-Shah Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality
21. The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris
22. One hundred and two cases of hemophilia A in Taiwan I. Clinical, laboratory, and family studies
23. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method
24. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes
25. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
26. Haemostasis factors in angina pectoris: Relation to gender, age and acute-phase reaction
27. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women
28. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: A 7-year follow-up
29. Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension
30. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to the acute phase reaction
31. Coagulation activity is increased in the left atrium of patients with mitral stenosis
32. Determinants of increased regional left atrial coagulant activity in patients with mitral stenosis
33. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis
34. Paroxysmal atrial fibrillation